VST Bio: Funding, Investors & Team (Oct 2026)
VST Bio is a biotechnology company that offers and develops treatment for vascular diseases.
VST Bio has raised $28.9M across 1 funding round on record, the most recent an undisclosed round of $28.9M announced in Nov 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
VST Bio Company Profile and Key Stats
Latest funding round on record: Nov 2025.
VST Bio Funding Rounds
VST Bio Founders and Leadership Team
Contact details for the VST Bio team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →VST Bio Funding Compared to Other Biotechnology Startups
VST Bio's latest round of $28.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like VST Bio in Biotechnology and San Diego
Companies Similar to VST Bio
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
VST Bio Funding FAQs
What does VST Bio do?
VST Bio is a biotechnology company that offers and develops treatment for vascular diseases.
How much funding has VST Bio raised?
VST Bio has raised $28.9M across 1 round on record. The most recent is an undisclosed round of $28.9M announced in Nov 2025.
When did VST Bio last raise funding?
VST Bio's most recent funding round on record is an undisclosed round of $28.9M, announced in Nov 2025.
Where is VST Bio headquartered?
VST Bio is based in San Diego, United States.
How does VST Bio's funding compare to other Biotechnology startups?
VST Bio's latest round of $28.9M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's VST Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for VST Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.